Pathogenetic Justification for the Use of Folates for the Prevention of Congenital Malformations
The frequency and severity of congenital malformations (CMF) do not tend to decline in modern society. CMF for etiologic factors are referred to the pathologies of a multifactorial nature. Among the many causative factors of CMF there is a hereditary predisposition.
The objective of the study was to increase the effectiveness of complex individualized prophylaxis of congenital malformations in women with polymorphic alleles of genes of folate cycle enzymes, the second phase of the detoxification system through the use of diagnostic, preventive, and therapeutic measures.
Materials and methods. 120 women of reproductive age who live in the city of Odessa and the Odessa region were examined. The alleles of the genes of the folate cycle enzymes of methylenetetrahydrofolate reductase (MTHFR), 5-methyltetrahydrofolate homocysteine methyltransferase reductase (MTRR), glutathione-S-transferase M1 (GSTM1), folate acid, cyanocobalamin were determined.
Results of the study and their discussion. The determination of the polymorphic alleles of the genes of the folate cycle enzymes of methylenetetrahydrofolate reductase (MTHFR), 5-methyltetrahydrofolate homocysteine methyltransferase reductase (MTRR), glutathione-S-transferase M1 (GSTM1), low folate, cyanocobalamin indicates the presence of a hereditary predisposition to the emergence of CMF, before and during pregnancy. Polymorphism of genes that control the synthesis of GSTM1 may alter the activity of detoxification enzymes. Expression of genes of GSTM1 enzymes begins in the embryonic period. Glutathione-dependent detoxification plays a key role in disinfecting of DNA peroxides. Mistakes of metabolism, functions of the corresponding enzymes are realized by chromosomal abnormalities and the risk of the occurrence of CMF, which requires the use of antioxidant therapy before and during pregnancy.
Conclusions. It was found that a high (about 55%) frequency of the polymorphic alleles of the genes of folate cycle enzymes MTHFR (homozygous – 10.0%, heterozygous – 16.7%), 5 MTRR (homozygous 12.5%, heterozygous – 15.5%) , the second phase of the GSTM1 detoxification system (homozygous – 13.3%, heterozygous – 15.8%), the content below the reference values of folic acid in 26.7%, cyanocobalamin – in 63.4% of observations indicates a hereditary predisposition and may contribute the emergence of CMF, which explains the expediency of timely use of preventive measures including folates, antioxidants.
Zaporozhan VN, Kordon VA, Bazhora YuI. Genetic medicine. Odes. med. univer. 2008; 432.
Liskovskiy SV. Clinical features of the course of labor and the postpartum period in pregnant women with cyanocobalamin deficiency. Zbirnyk naukovykh prats Asotsiatsiyi akusheriv-hinekolohiv Ukrayiny. Intermed: 2011; 536-537.
Mishchenko VP. A differentiated approach to the prevention of gestational complications in women of different nationalities. Zbirnyk naukovykh prats Asotsiatsiyi akusheriv-hinekolohiv Ukrayiny. Intermed: 2017; 1 (39): 109-113.
Mishchenko VP, Rudenko IV, Zaporozhchenko MB, Lavrynenko AL. Peculiarities of pre-gravida preparing of women of different nationalities. Aktualni pytannia pediatriyi, akusherstva ta hinekolohiyi. 2017; 1 (19): 105-110.
Rudenko IV. Preconceptional prophylaxis of development of congenital malformations of a multifactorial nature. Problemy, dostizheniya i perspektivy razvitiya mediko-biologicheskikh nauk i prakticheskogo zdravookhraneniya: trudy Krymskogo gos.med. un-ta im. SI. Georgievskogo. Simferopol: Izd. centr KGMU: 2009; 145(2): 229-231.
Zaporozhan VM, Serdiuk AM, Bazhora YuI et al. Hereditary diseases and congenital malformations in perinatal practice. Odes. derzh. med. univer. 2008; 356.
Copyright (c) 2017 V Mischenko, I Rudenko, M Holubenko, A Lavrinenko, K Tumasian
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).